COVID-19 Vaccine Development
Over the past 22 years, Texas Children’s Center for Vaccine Development at Baylor College of Medicine has acquired an international reputation as an academic-based product development partnership. Its mission is to advance vaccines for poverty-related neglected tropical diseases and emerging diseases.In 2020, their team took advantage of their expertise in the field of SARS and MERS vaccine R&D to form a strategic global alliance to accelerate the design, engineering, process development, technological transfer and preclinical evaluation of a COVID-19 subunit vaccine. The goal was to advance a vaccine that is low-cost, affordable, safe, effective and globally accessible.In this webinar, Maria Elena Bottazzi, Associate Dean of the National School of Tropical Medicine at Baylor College of Medicine, provides an overview of this program for a recombinant protein-based COVID-19 vaccine and its successful technological transfer for global access.
View to Watch On-Demand
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.